GlycoNet, partners fund $3.5 million in health research
EDMONTON – The Canadian Glycomics Network (GlycoNet) along with partner institutions recently awarded more than $3.5 million in grants to fund exploratory research in the area of glycomics to benefit human health.
The funds are distributed to more than 36 researchers at 18 institutions across Canada. These funds will support research to benefit human health, such as improved imaging of a key enzyme in Parkinson’s disease, understanding why Alzheimer’s-causing plaques form in the brain, developing an oral medication to fight drug-resistant fungi, and assessing a plant-based therapy to treat and prevent kidney stones.
“We are pleased to fund this latest round of research proposals and are confident our innovative and entrepreneurial culture will help this research impact the health and well-being of Canadians in years to come,” says GlycoNet Scientific Director, Dr. Todd Lowary. “We continue to build critical mass in our research areas and count more than 114 researchers in our network who are the top in their field.”